BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29726011)

  • 1. MiR-505 mediates methotrexate resistance in colorectal cancer by targeting RASSF8.
    Chen Y; Bian L; Zhang Y
    J Pharm Pharmacol; 2018 Jul; 70(7):937-951. PubMed ID: 29726011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
    Xian D; Zhao Y
    J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma.
    Xu W; Li Z; Zhu X; Xu R; Xu Y
    Med Sci Monit; 2018 Dec; 24():8812-8821. PubMed ID: 30518744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASSF8-AS1 displays low expression in colorectal cancer and up-regulates RASSF8 to suppress cell invasion and migration.
    Zhang X; Sun P; Yang W; Li S; Jia H; Wang W; Jiang S; Wang L; Liu X; Liang L; Zi W
    Pathol Res Pract; 2022 Sep; 237():153996. PubMed ID: 35839610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
    Yan L; Yao J; Qiu J
    Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP.
    Li C; Du X; Xia S; Chen L
    Oncol Rep; 2018 Jul; 40(1):252-260. PubMed ID: 29750311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells.
    Bazavar M; Fazli J; Valizadeh A; Ma B; Mohammadi E; Asemi Z; Alemi F; Maleki M; Xing S; Yousefi B
    Pathol Res Pract; 2020 Nov; 216(11):153176. PubMed ID: 32861171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1.
    Zhang GJ; Li JS; Zhou H; Xiao HX; Li Y; Zhou T
    J Exp Clin Cancer Res; 2015 Jul; 34(1):73. PubMed ID: 26223867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.
    Chang SW; Yue J; Wang BC; Zhang XL
    Int J Clin Exp Pathol; 2015; 8(10):12853-60. PubMed ID: 26722476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.
    Li C; Gao Y; Li Y; Ding D
    Biochem Biophys Res Commun; 2017 Sep; 491(2):552-557. PubMed ID: 28302487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance.
    Yuan LL; Li L; Liu JN; Mei J; Lei CJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5499-5507. PubMed ID: 30229821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-224 promotes non-small cell lung cancer cell proliferation by directly targeting RASSF8.
    Wang L; Liu W; Zhang YP; Huang XR
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3223-3231. PubMed ID: 28770961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8.
    Huang Y; Li Y; Wang FF; Lv W; Xie X; Cheng X
    PLoS One; 2016; 11(9):e0162378. PubMed ID: 27626930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).
    Zhang T; Cai X; Li Q; Xue P; Chen Z; Dong X; Xue Y
    Oncotarget; 2016 Jul; 7(27):42225-42240. PubMed ID: 27302926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.